Botulinum Toxin A for the Treatment of Chronic Lumbar Back Pain
Status:
Unknown status
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
This study will assess the efficacy and the duration of efficacy of Botulinum toxin A
(Botox®) injected into the lumbar paraspinal muscles for reducing pain and disability in
subjects suffering from chronic low back pain of six months duration or longer and arising
from an identifiable muscle strain injury or back trauma. The treatment modality and
techniques used are based on a successful prior 4 month open-labeled pilot study done by this
research group, but will employ a prospective double-blind, randomized, cross-over design to
control for any placebo or mechanical trigger-point injection effects. Subjects will also be
assessed for a longer duration to better define the duration of efficacy.
Phase:
Phase 4
Details
Lead Sponsor:
Walter Reed Army Medical Center
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA